No Data
YONGHE MEDICAL: INTERIM REPORT 2024
On August 23, there was a buyback consortium, with companies like tencent and hsbc holdings buying back their shares. Tencent Holdings spent 1.002 billion Hong Kong dollars on the buyback.
According to the disclosure documents from HKEX on August 26th, Tencent Holdings (00700.HK) and HSBC Holdings (00005.HK) have repurchased shares. 1. Tencent Holdings (00700.HK) repurchased 2.66 million ordinary shares on August 23rd, involving an amount of HKD 1.002 billion, with a repurchase price ranging from HKD 378.4 to HKD 373.6 per share. Since the authorization of the repurchase resolution, the cumulative number of securities repurchased is 0.118 billion shares, accounting for 1.249% of the number of shares issued when the ordinary resolution was passed. 2. HSBC Holdings (00005.HK) repurchased... (The text is incomplete, please provide the complete text.)
Yonghe Medical (02279) spent approximately 0.0658 million Hong Kong dollars to repurchase 0.1 million shares on August 23.
Yonghe Medical (02279) announced that it will spend approximately 0.0658 million Hong Kong dollars to repurchase shares on August 23, 2024...
A comprehensive understanding of the 2024 interim performance report of Yonghe Medical (2279.HK)
On August 22nd, Yonghe Medical (2279.HK) released its 2024 semi-annual performance report. The specific performance will be explained through an infographic.
Yonghe Medical (2279.HK): Performance driven by transformation, unlocking new opportunities and value.
I was pleasantly surprised to see that Yonghe Medical in the field of hair transplantation has returned to the track of stable operation against the trend.
《Performance》Yonghe Medical (02279.HK) narrowed its interim loss to 0.139 billion RMB.
Yonghe Medical (02279.HK) announced its interim performance for the six months ended in June, with revenue recorded at 0.9 billion RMB (same below), an 8.7% year-on-year increase. The loss narrowed from 0.226 billion yuan in the same period last year to 0.139 billion yuan, with a loss per share of 28 fen. No interim dividend will be distributed.
No Data
No Data